Increased Malonyl-CoA Levels in Muscle From Obese and Type 2 Diabetic Subjects Lead to Decreased Fatty Acid Oxidation and Increased Lipogenesis; Thiazolidinedione Treatment Reverses These Defects
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
Increased accumulation of fatty acids and their derivatives can impair insulin-stimulated glucose disposal by skeletal muscle. To characterize the nature of the defects in lipid metabolism and to evaluate the effects of thiazolidinedione treatment, we analyzed the levels of triacylglycerol, long-chain fatty acyl-coA, malonyl-CoA, fatty acid oxidation, AMP-activated protein kinase (AMPK), acetyl-CoA carboxylase (ACC), malonyl-CoA decarboxylase, and fatty acid transport proteins in muscle biopsies from nondiabetic lean, obese, and type 2 subjects before and after an euglycemic-hyperinsulinemic clamp as well as pre–and post–3-month rosiglitazone treatment. We observed that low AMPK and high ACC activities resulted in elevation of malonyl-CoA levels and lower fatty acid oxidation rates. These conditions, along with the basal higher expression levels of fatty acid transporters, led accumulation of long-chain fatty acyl-coA and triacylglycerol in insulin-resistant muscle. During the insulin infusion, muscle fatty acid oxidation was reduced to a greater extent in the lean compared with the insulin-resistant subjects. In contrast, isolated muscle mitochondria from the type 2 subjects exhibited a greater rate of fatty acid oxidation compared with the lean group. All of these abnormalities in the type 2 diabetic group were reversed by rosiglitazone treatment. In conclusion, these studies have shown that elevated malonyl-CoA levels and decreased fatty acid oxidation are key abnormalities in insulin-resistant muscle, and, in type 2 diabetic patients, thiazolidinedione treatment can reverse these abnormalities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The concentration of IMTG, fatty acyl-CoAs, DAG, and/or ceramide are elevated in skeletal muscle from obese humans, genetically obese rats, and HFD-fed, obese mice in association with insulin resistance (53)(54)(55)(56)(57).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [56]
Experimental — accuracy not yet measuredIn the citing paper
“Thus, clinical studies have demonstrated that obese, insulin-resistant, and type 2 diabetic individuals do not exhibit a reduced capacity to oxidize fatty acids (73,74) and have normal, or even increased, mitochondrial function, as compared with lean controls (56,75).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 1×
“This could have subsequent deleterious effects through oxidative damage (39,55,56).”
BackgroundYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Srere, P. A. (1969) · Methods in Enzymology · doi:10.1016/0076-6879(69)13005-0 · Cited by 2,005
Kelley, D. E., Goodpaster, B., Wing, R. R., & Simoneau, J.-A. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.6.e1130 · Cited by 1,096
Tomas, E., Tsao, T.-S., Saha, A. K., Murrey, H. E., Zhang, C. C., Itani, S. I., Lodish, H. F., & Ruderman, N. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222657499 · Cited by 973
Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes
Ritov, V. B., Menshikova, E. V., He, J., Ferrell, R. E., Goodpaster, B. H., & Kelley, D. E. (2005) · Diabetes · doi:10.2337/diabetes.54.1.8 · Cited by 887
Winder, W. W., & Hardie, D. G. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.270.2.e299 · Cited by 799
Yu, J. G., Javorschi, S., Hevener, A. L., Kruszynska, Y. T., Norman, R. A., Sinha, M., & Olefsky, J. M. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2968 · Cited by 725
Self-citationMalonyl-CoA, fuel sensing, and insulin resistance
Ruderman, N. B., Saha, A. K., Vavvas, D., & Witters, L. A. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.1.e1 · Cited by 650
Lipid oxidation is reduced in obese human skeletal muscle
Kim, J.-Y., Hickner, R. C., Cortright, R. L., Dohm, G. L., & Houmard, J. A. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.5.e1039 · Cited by 634 · cited 1×
“These findings are consistent with previous reports because other studies have shown diminished basal fatty acid oxidation in insulin-resistant muscle (16,27,51,52).”
ResultMitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone.
Wilson-Fritch, L., Nicoloro, S., Chouinard, M., Lazar, M. A., Chui, P. C., Leszyk, J., Straubhaar, J., Czech, M. P., & Corvera, S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21752 · Cited by 616
Muscle-specific Pparg deletion causes insulin resistance
Hevener, A. L., He, W., Barak, Y., Le, J., Bandyopadhyay, G., Olson, P., Wilkes, J., Evans, R. M., & Olefsky, J. (2003) · Nature Medicine · doi:10.1038/nm956 · Cited by 492
Self-citationPrevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes
Green, K., Brand, M. D., & Murphy, M. P. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s110 · Cited by 490
Metabolic syndrome: Definition, pathophysiology, and mechanisms
Miranda, P. J., DeFronzo, R. A., Califf, R. M., & Guyton, J. R. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.07.013 · Cited by 479
AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome
Ruderman, N., & Prentki, M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1344 · Cited by 451
An, J., Muoio, D. M., Shiota, M., Fujimoto, Y., Cline, G. W., Shulman, G. I., Koves, T. R., Stevens, R., Millington, D., & Newgard, C. B. (2004) · Nature Medicine · doi:10.1038/nm995 · Cited by 450
Peroxisome proliferator-activated receptor γ in diabetes and metabolism
Rangwala, S. M., & Lazar, M. A. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.03.012 · Cited by 450
Shetty, G. K., Economides, P. A., Horton, E. S., Mantzoros, C. S., & Veves, A. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2450 · Cited by 415
Oxidative Capacity, Lipotoxicity, and Mitochondrial Damage in Type 2 Diabetes
Schrauwen, P., & Hesselink, M. K. C. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1412 · Cited by 408 · cited 2×
“This could have subsequent deleterious effects through oxidative damage (39,55,56).”
BackgroundResultAbu-Elheiga, L., Oh, W., Kordari, P., & Wakil, S. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1733877100 · Cited by 389
Musi, N., Fujii, N., Hirshman, M. F., Ekberg, I., Fröberg, S., Ljungqvist, O., Thorell, A., & Goodyear, L. J. (2001) · Diabetes · doi:10.2337/diabetes.50.5.921 · Cited by 371
Skeletal muscle fat oxidation: Timing and flexibility are everything
Kelley, D. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25758 · Cited by 298 · cited 1×
“(54), which suggests that insulin-resistant muscle tissue does not flexibly switch fuel oxidation from fat to glucose in response to insulin and meals.”
BackgroundHajri, T., Han, X. X., Bonen, A., & Abumrad, N. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14596 · Cited by 276
Stahl, A., Evans, J. G., Pattel, S., Hirsch, D., & Lodish, H. F. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00143-0 · Cited by 259
F ATTY A CID T RANSPORT A CROSS M EMBRANES: Relevance to Nutrition and Metabolic Pathology
Hajri, T., & Abumrad, N. A. (2002) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.22.020402.130846 · Cited by 248
Hajri, T., Han, X. X., Bonen, A., & Abumrad, N. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214596 · Cited by 231
Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane
Luiken, J. J. F. P., Dyck, D. J., Han, X.-X., Tandon, N. N., Arumugam, Y., Glatz, J. F. C., & Bonen, A. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00419.2001 · Cited by 229
Miyazaki, Y., Mahankali, A., Wajcberg, E., Bajaj, M., Mandarino, L. J., & DeFronzo, R. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0190 · Cited by 227
Kim, J. K., Gimeno, R. E., Higashimori, T., Kim, H.-J., Choi, H., Punreddy, S., Mozell, R. L., Tan, G., Stricker-Krongrad, A., Hirsch, D. J., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18917 · Cited by 226
Human Acetyl-CoA Carboxylase 2
Abu-Elheiga, L., Almarza-Ortega, D. B., Baldini, A., & Wakil, S. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10669 · Cited by 220
PPARγ-mediated insulin sensitization: the importance of fat versus muscle
Kintscher, U., & Law, R. E. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00440.2004 · Cited by 220
Kim, J. K., Gimeno, R. E., Higashimori, T., Kim, H.-J., Choi, H., Punreddy, S., Mozell, R. L., Tan, G., Stricker-Krongrad, A., Hirsch, D. J., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200418917 · Cited by 212
Bandyopadhyay, G. K., Yu, J. G., Ofrecio, J., & Olefsky, J. M. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2351 · Cited by 210 · cited 2×
“achieved during the clamp, the information is the same as in the previous publication (26).”
MethodResultSelf-citationChen, M. B., McAinch, A. J., Macaulay, S. L., Castelli, L. A., O’Brien, P. E., Dixon, J. B., Cameron-Smith, D., Kemp, B. E., & Steinberg, G. R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1980 · Cited by 200
McGarry, J. D., Stark, M. J., & Foster, D. W. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34394-6 · Cited by 187
Rasmussen, B. B., Holmbäck, U. C., Volpi, E., Morio-Liondore, B., Paddon-Jones, D., & Wolfe, R. R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215715 · Cited by 177
Koves, T. R., Noland, R. C., Bates, A. L., Henes, S. T., Muoio, D. M., & Cortright, R. N. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00391.2004 · Cited by 176
Loviscach, M., Rehman, N., Carter, L., Mudaliar, S., Mohadeen, P., Ciaraldi, T. P., Veerkamp, J. H., & Henry, R. R. (2000) · Diabetologia · doi:10.1007/s001250050048 · Cited by 176
Bruce, C. R., Mertz, V. A., Heigenhauser, G. J. F., & Dyck, D. J. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3154 · Cited by 165
Antinozzi, P. A., Segall, L., Prentki, M., McGarry, J., & Newgard, C. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16146 · Cited by 149
Chabowski, A., Coort, S. L., Calles-Escandón, J., Tandon, N. N., Glatz, J. F. C., Luiken, J. J. F. P., & Bonen, A. (2005) · FEBS Letters · doi:10.1016/j.febslet.2004.11.118 · Cited by 130
Boden, G., Homko, C., Mozzoli, M., Showe, L. C., Nichols, C., & Cheung, P. (2005) · Diabetes · doi:10.2337/diabetes.54.3.880 · Cited by 129
The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes
Tan, G. D., Fielding, B. A., Currie, J. M., Humphreys, S. M., D�sage, M., Frayn, K. N., Laville, M., Vidal, H., & Karpe, F. (2004) · Diabetologia · doi:10.1007/s00125-004-1619-9 · Cited by 126
Ahuja, H. S., Liu, S., Crombie, D. L., Boehm, M. F., Leibowitz, M. D., Heyman, R. A., Depré, C., Nagy, L., Tontonoz, P., & Davies, P. J. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.4.765 · Cited by 115
AMP-Activated Protein Kinase Is Not Down-Regulated in Human Skeletal Muscle of Obese Females
Steinberg, G. R., Smith, A. C., van Denderen, B. J. W., Chen, Z., Murthy, S., Campbell, D. J., Heigenhauser, G. J. F., Dyck, D. J., & Kemp, B. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0308 · Cited by 97 · cited 2×
“A third study found no change in AMP kinase activity, but it compared lean and obese nondiabetic female subjects (43).”
BackgroundResultHøjlund, K., Mustard, K. J., Stæhr, P., Hardie, D. G., Beck‐Nielsen, H., Richter, E. A., & Wojtaszewski, J. F. P. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00326.2003 · Cited by 87
Garcia‐Martínez, C., Marotta, M., Moore‐Carrasco, R., Guitart, M., Camps, M., Busquets, S., Montell, E., & Gómez-Foix, A. M. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00271.2004 · Cited by 86
Basic disturbances in skeletal muscle fatty acid metabolism in obesity and type 2 diabetes mellitus
Blaak, E. E. (2004) · Proceedings of the Nutrition Society · doi:10.1079/pns2004361 · Cited by 83 · cited 1×
“These findings are consistent with previous reports because other studies have shown diminished basal fatty acid oxidation in insulin-resistant muscle (16,27,51,52).”
ResultThiazolidinedione Treatment Prevents Free Fatty Acid–Induced Insulin Resistance in Male Wistar Rats
Hevener, A. L., Reichart, D. R., Janež, A., & Olefsky, J. M. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2316 · Cited by 78
Self-citationWilmsen, H. M., Ciaraldi, T. P., Carter, L., Reehman, N., Mudaliar, S. R. D., & Henry, R. R. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00491.2001 · Cited by 76
Effect of Training on Muscle Triacylglycerol and Structural Lipids
Helge, J. W., & Dela, F. (2003) · Diabetes · doi:10.2337/diabetes.52.8.1881 · Cited by 74
Soo, B., Ciaraldi, T. P., Park, K. S., Carter, L., Mudaliar, S. R. D., & Henry, R. R. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00141.2004 · Cited by 70
Båvenholm, P., Kuhl, J., Pigon, J., Saha, A. K., Ruderman, N. B., & Efendić, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020330 · Cited by 63
Chronic rosiglitazone treatment restores AMPKα2 activity in insulin-resistant rat skeletal muscle
Lessard, S. J., Chen, Z., Watt, M. J., Hashem, M., Reid, J. J., Febbraio, M. A., Kemp, B. E., & Hawley, J. A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00096.2005 · Cited by 62
Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
Frías, J. P., Yu, J., Kruszynska, Y. T., & Olefsky, J. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.64 · Cited by 61
Self-citationKuhl, J., Ruderman, N. B., Musi, N., Goodyear, L. J., Patti, M., Crunkhorn, S., Dronamraju, D., Thorell, A., Nygren, J., Ljungkvist, O., et al. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00341.2005 · Cited by 56
The Association between Plasma Adiponectin and Insulin Sensitivity in Humans Depends on Obesity
Kantartzis, K., Fritsche, A., Tschritter, O., Thamer, C., Haap, M. M., Schäfer, S., Stümvoll, M., Häring, H., & Stefan, N. (2005) · Obesity Research · doi:10.1038/oby.2005.206 · Cited by 49
Fatty acid oxidation in human and rat heart. Comparison of cell-free and cellular systems
Glatz, J. F. C., Jacobs, A. E. M., & Veerkamp, J. H. (1984) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(84)90012-2 · Cited by 39
Fatty acid transport proteins and insulin resistance
Fisher, R. M., & Gertow, K. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000162322.39548.b1 · Cited by 38
Kerner, J., & Hoppel, C. L. (2002) · Analytical Biochemistry · doi:10.1006/abio.2002.5696 · Cited by 34
Cited by
Steinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,637
Insulin sensitivity: Modulation by nutrients and inflammation
Schenk, S., Saberi, M., & Olefsky, J. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34260 · Cited by 1,191
Self-citationRegulation of mitochondrial biogenesis
Jornayvaz, F. R., & Shulman, G. I. (2010) · Essays in Biochemistry · doi:10.1042/bse0470069 · Cited by 1,119
“Indeed, a study showed that rosiglitazone increased AMPK activity in muscle in Type 2 diabetes and obesity [59].”
BackgroundAMPK and SIRT1: a long-standing partnership?
Ruderman, N. B., Julia Xu, X., Nelson, L., Cacicedo, J. M., Saha, A. K., Lan, F., & Ido, Y. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00745.2009 · Cited by 903
AMPK, insulin resistance, and the metabolic syndrome
Ruderman, N. B., Carling, D., Prentki, M., & Cacicedo, J. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67227 · Cited by 873
Metadata
- Authors
- Bandyopadhyay, G. K., Yu, J. G., Ofrecio, J., & Olefsky, J. M.
- Affiliations
- University of California San Diego (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2006-08-01
- Volume
- 55
- Issue
- 8
- Pages
- 2277-2285
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2110549950
- Cited by
- 291
- References
- 62
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 7 · 2023: 2 · 2022: 9 · 2021: 12 · 2020: 17 · 2019: 10 · 2018: 7 · 2017: 11 · 2016: 14 · 2015: 13 · 2014: 17 · 2013: 16 · 2012: 14
- FWCI
- 11.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Diabetes (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCLA - Biblioteca de Ciencias de la Salud (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-33651, DK-16964)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- malonyl-CoA, fatty acid oxidation, lipogenesis, type 2 diabetes, obesity, insulin resistance, skeletal muscle, AMPK, acetyl-CoA carboxylase, fatty acid transporters, triglyceride accumulation, rosiglitazone, thiazolidinediones, mitochondrial fatty acid oxidation, insulin-stimulated glucose disposal
- MeSH terms
- Rosiglitazone, Acetyl-CoA Carboxylase, Acyl Coenzyme A, Adult, Carboxy-Lyases, Diabetes Mellitus, Type 2, Fatty Acids, Female, Humans, Hypoglycemic Agents, Insulin Resistance, Lipids, Male, Malonyl Coenzyme A, Middle Aged, Mitochondria, Muscle, Multienzyme Complexes, Obesity, Oxidation-Reduction, Triglycerides, Glucose Clamp Technique, Protein Serine-Threonine Kinases, Muscle, Skeletal, Thiazolidinediones, Fatty Acid Transport Proteins, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.